Search

everythinglearnresearchcommunity

for

Search:↓

Adalimumab significantly improves quality of life for patients with moderate to severe hidradenitis suppurativa.

Alopecia areata treatments often don't lead to lasting improvement.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Ritlecitinib effectively reduces severe hair loss in alopecia areata over 24 months.

Spironolactone improved hair density and quality in women with hair loss.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Patient-reported outcomes better reflect the quality of life impact of alopecia areata than traditional severity scores.

Using Calcipotriol with Clobetasol is more effective for treating Alopecia Areata than using Clobetasol alone.

Low-dose oral minoxidil does not increase pericardial effusions in alopecia patients.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

A change in SALT scores of 42 or 43 indicates meaningful improvement in alopecia areata treatment.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

The Swedish Hairdex-S is a reliable tool for assessing quality of life in Alopecia Areata patients.

Low-dose oral minoxidil is generally safe for treating hair loss, with mostly mild side effects.

Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.

An emollient PLUS balm with ADE-G1 significantly improved skin dryness and quality of life in cancer patients with xerosis.

DLQI is a reasonable quality-of-life measure for alopecia patients, but more research is needed.

PDO threads are effective and safe for treating alopecia, but more research is needed.

Skin disease activity scores can help decide when skin symptoms no longer affect the quality of life in patients with mild dermatomyositis.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

Bexarotene 1% topical gel helped some patients with alopecia areata regrow hair.

Dutasteride effectively and safely treats male hair loss for over a year.

Low-dose oral minoxidil is effective for alopecia even with other medications.

3α-AdiolG is a good marker for androgen activity in women with excessive hair growth and decreases with anti-androgen treatment.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

Higher concentrations of dithranol can help regrow hair in severe alopecia areata.

Cromolyn sodium oleate gel is more effective and safer for treating atopic dermatitis than dexamethasone.

Most adverse reactions to the treatment were mild, with nausea being the most common.